Clinical Trial Update: Neoadjuvant mFOLFOXIRI Chemotherapy Alone for Extramural Vascular Invasion Positive Locally Advanced Rectal Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating neoadjuvant mFOLFOXIRI chemotherapy alone for locally advanced rectal cancer with extramural vascular invasion.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rectal Cancer

Drugs mentioned

• MFOLFOXIRI

Snippet

Sponsor: First Affiliated Hospital of Zhejiang University | Conditions: Locally Advanced Rectal Cancer | Phase 2 | Status: UNKNOWN